The Impact of COVID-19 pandemic and lockdown on cardiometabolic status on patients without evidence of SARS CoV-2 infection in three regions of Latin America. A sub-study of the CorCOVID LATAM study

CAMILETTI J; RENNA NF; LOPEZ SANTI R; BARANCHUK A

Glasgow

Congreso; Joint Meeting ESH-ISH 2021; 2021

International society of Hypertension

Objective: Background The purpose of the study was to evaluate regional relateddifferences in Latin America on the impact of the pandemic in cardiometabolicpatients without evidence of SARS-CoV-2 infection.Methods: A cross-sectional survey was conducted which included 38 questionsabout demography, clinical condition, change of health habits, medical treatmentsto cardio metabolic patients in outpatient follow-up. A total of 66 researchers from13 Latin American countries enrolled patients from June 15 to July 15, 2020.The countries were divided into 3 geographic regions Region1 (NCCR) North,Central, and Caribbean Region; Region2 (AR) Andean Region; Region3 (SCR)Southern Cone Region. Isolation measures were estimated from national reportsand correlated using the Spearman R coeffi cient.Design and method: 4216 patients were analyzed, NCCR (33.82%); AR(32.23%) SCR (33.94%). Signifi cant differences were found between regions inthe AR, SCR and NCCR, in age, unemployment, CV risk, adherence, percentageof smokers, type of diet and vaccination coverage. This analysis of habitual medicationshowed, that discontinued medication was greater in AR, reaching almost 30% (1 in 3 patients), to a lesser extent in NCCR and ultimately less in SCR,showing a signifi cant difference between zones (p